EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Beyond mecA : a two-tiered mechanism and regulatory rewiring drive high-level ceftaroline resistance in clinical MRSA

Melissa Sassman, Michele Karolak, Margeurite Dallaire, Claire E Schaffer, Carlos Gartner, Calvin Vary, Roberto R Rosato, Adriana E Rosato iD

Antimicrobial Agents and Chemotherapy · 2026

DOI: 10.1128/aac.00586-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2026. Verfasst von Melissa Sassman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Molecular Medicine, MaineHealth Institute for Research, Scarborough, Maine, USA. Hauptthemen laut MEDLINE: Cephalosporins, Methicillin-Resistant Staphylococcus aureus, Bacterial Proteins, Anti-Bacterial Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High-level resistance to ceftaroline, a fifth-generation β-lactam critical for treating methicillin-resistant Staphylococcus aureus (MRSA), is an emerging threat to global health. While resistance is traditionally attributed to mecA -mediated expression of PBP2a, our study reveals a previously unrecognized mechanism. We show that high-level resistance to ceftaroline can arise independently of ceftaroline exposure through a collateral pathway triggered by carbapenems typically used to treat Gram-negative infections. Our findings reveal a two-tiered adaptive process. First, meropenem selects non-synonymous mutations in rpoB , a core transcriptional regulator, which primes resistance by reprogramming gene expression. These changes consistently co-occur with a key substitution in pbp1 (H499R), an essential protein for cell division, and specific mecA variants (Y446H, E447K) following ceftaroline exposure. Second, resistance is stabilized through regulatory and signaling adaptations, with elevated basal levels of the oxidative stress regulator Spx and its adaptor protein TrfA supporting the altered cellular state. Proteomic and biophysical studies revealed direct binding of TrfA to GdpP, the phosphodiesterase for cyclic-di-AMP, linking this regulatory circuit to elevated c-di-AMP levels and resistance maintenance. Our findings challenge the assumption that ceftaroline resistance is driven solely by PBP2a alterations and reveal how collateral resistance pathways can be activated by broad-spectrum antibiotic use. This study highlights the evolutionary capacity of MRSA to circumvent antibiotic pressure and underscores the need for improved antimicrobial stewardship.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CephalosporinsMethicillin-Resistant Staphylococcus aureusBacterial ProteinsAnti-Bacterial AgentsPenicillin-Binding ProteinsCeftarolineMicrobial Sensitivity TestsThird Generation CephalosporinsMutationGene Expression Regulation, BacterialHumans

Stichwörter der Autor:innen

MRSAceftarolinecell wall remodelingresistance mechanismsrpoB

Substanzen

CeftarolineCephalosporinsBacterial ProteinsAnti-Bacterial AgentsPenicillin-Binding ProteinsmecA protein, Staphylococcus aureusThird Generation Cephalosporins

Autor:innen und Institutionen

  • Center for Molecular Medicine, MaineHealth Institute for Research, Scarborough, Maine, USA.
  • Tufts University School of Medicine, Boston, Massachusetts, USA.
  • Graduate School of Biomedical Science and Engineering, University of Maine, Orono, Maine, USA.

ORCID-Profile: Adriana E Rosato

Förderung

  • NIAID NIH HHS

Zitieren

APA

Sassman, M., Karolak, M., Dallaire, M., Schaffer, C. E., Gartner, C., Vary, C., Rosato, R. R., & Rosato, A. E. (2026). Beyond mecA : a two-tiered mechanism and regulatory rewiring drive high-level ceftaroline resistance in clinical MRSA. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00586-25

Vancouver

Sassman M, Karolak M, Dallaire M, Schaffer CE, Gartner C, Vary C, et al. Beyond mecA : a two-tiered mechanism and regulatory rewiring drive high-level ceftaroline resistance in clinical MRSA. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.00586-25

BibTeX
@article{Sassman2026,
  author = {Sassman, Melissa and Karolak, Michele and Dallaire, Margeurite and Schaffer, Claire E and Gartner, Carlos and Vary, Calvin and Rosato, Roberto R and Rosato, Adriana E},
  title = {Beyond mecA : a two-tiered mechanism and regulatory rewiring drive high-level ceftaroline resistance in clinical MRSA},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  doi = {10.1128/aac.00586-25}
}
Kostenlos starten →